(19)
(11) EP 4 771 138 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24772864.5

(22) Date of filing: 30.08.2024
(51) International Patent Classification (IPC): 
C12N 9/12(2006.01)
C12N 15/10(2006.01)
C12N 9/22(2006.01)
C12N 15/11(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 9/22; C12N 15/102; C12N 2310/20; C12N 15/113; C12N 9/1276; C07K 2319/00; C07K 2319/80
(86) International application number:
PCT/US2024/044701
(87) International publication number:
WO 2025/049928 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.09.2023 US 202363580168 P
01.09.2023 US 202363580188 P
15.02.2024 US 202463553974 P
25.04.2024 US 202463638559 P

(71) Applicant: Arbor Biotechnologies, Inc.
Cambridge, MA 02140 (US)

(72) Inventors:
  • ALFONSE, Lauren E.
    Cambridge, Massachusetts 02140 (US)
  • JAKIMO, Noah M.
    Cambridge, Massachusetts 02140 (US)
  • MABEN, Zachary J.
    Cambridge, Massachusetts 02140 (US)
  • TORGERSON, Chad D.
    Cambridge, Massachusetts 02140 (US)
  • WATTERS, Kyle E.
    Cambridge, Massachusetts 02140 (US)

(74) Representative: Maiwald GmbH 
Elisenhof Elisenstraße 3
80335 München
80335 München (DE)

   


(54) REVERSE TRANSCRIPTION-MEDIATED GENE EDITING SYSTEMS AND USES THEREOF